{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T15:03:09Z","timestamp":1743087789046,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":63,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071618912"},{"type":"electronic","value":"9781071618929"}],"license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1892-9_7","type":"book-chapter","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T17:06:35Z","timestamp":1639674395000},"page":"117-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System"],"prefix":"10.1007","author":[{"given":"Jyoti","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Surjit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3389\/fmicb.2016.01419","volume":"7","author":"Y Nan","year":"2016","unstructured":"Nan Y, Zhang YJ (2016) Molecular biology and infection of hepatitis E virus. Front Microbiol 7:1419","journal-title":"Front Microbiol"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/apt.14109","volume":"46","author":"MC Donnelly","year":"2017","unstructured":"Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ (2017) Review article: hepatitis E\u2014a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther 46:126\u2013141","journal-title":"Aliment Pharmacol Ther"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/v11050456","volume":"11","author":"PP Primadharsini","year":"2019","unstructured":"Primadharsini PP, Nagashima S, Okamoto H (2019) Genetic variability and evolution of hepatitis E virus. Viruses 11:456","journal-title":"Viruses"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/v8080212","volume":"8","author":"S Lhomme","year":"2016","unstructured":"Lhomme S, Marion O, Abravanel F, Chapuy-Regaud S, Kamar N, Izopet J (2016) Hepatitis E pathogenesis. Viruses 8:212","journal-title":"Viruses"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.86","volume":"3","author":"N Kamar","year":"2017","unstructured":"Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, Dalton HR (2017) Hepatitis E virus infection. Nat Rev Dis Primers 3:1\u20136","journal-title":"Nat Rev Dis Primers"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJMra1204512","volume":"367","author":"JH Hoofnagle","year":"2012","unstructured":"Hoofnagle JH, Nelson KE, Purcell RH (2012) Hepatitis E. N Engl J Med 367:1237\u20131244","journal-title":"N Engl J Med"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/liv.13037","volume":"36","author":"N Kamar","year":"2016","unstructured":"Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR (2016) Extrahepatic manifestations of hepatitis E virus. Liver Int 36:467\u2013472","journal-title":"Liver Int"},{"key":"7_CR8","unstructured":"World Health Organization. Hepatitis E. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrgastro.2017.150","volume":"15","author":"I Nimgaonkar","year":"2018","unstructured":"Nimgaonkar I, Ding Q, Schwartz RE, Ploss A (2018) Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol 15:96","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1086\/504322","volume":"42","author":"D Boccia","year":"2006","unstructured":"Boccia D, Guthmann JP, Klovstad H, Hamid N, Tatay M, Ciglenecki I, Nizou JY, Nicand E, Guerin PJ (2006) High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 42:1679\u20131684","journal-title":"Clin Infect Dis"},{"key":"7_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1929","volume":"27","author":"MT P\u00e9rez-Gracia","year":"2017","unstructured":"P\u00e9rez-Gracia MT, Suay-Garc\u00eda B, Mateos-Lindemann ML (2017) Hepatitis E and pregnancy: current state. Rev Med Virol 27:e1929","journal-title":"Rev Med Virol"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00430-016-0484-8","volume":"206","author":"J Teixeira","year":"2017","unstructured":"Teixeira J, Mesquita JR, Pereira SS, Oliveira RM, Abreu-Silva J, Rodrigues A, Myrmel M, Stene-Johansen K, \u00d8verb\u00f8 J, Gon\u00e7alves G, Nascimento MS (2017) Prevalence of hepatitis E virus antibodies in workers occupationally exposed to swine in Portugal. Med Microbiol Immunol 206:77\u201381","journal-title":"Med Microbiol Immunol"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-3148.2006.00652.x","volume":"16","author":"E Boxall","year":"2006","unstructured":"Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, Teo CG (2006) Transfusion-transmitted hepatitis E in a \u2018nonhyperendemic\u2019 country. Transfus Med 16:79\u201383","journal-title":"Transfus Med"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar N, Selves J, Mansuy JM, Ouezzani L, P\u00e9ron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358:811\u2013817","journal-title":"N Engl J Med"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.virusres.2007.02.002","volume":"127","author":"H Okamoto","year":"2017","unstructured":"Okamoto H (2017) Genetic variability and evolution of hepatitis E virus. Virus Res 127:216\u2013228","journal-title":"Virus Res"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"e1005521","DOI":"10.1371\/journal.ppat.1005521","volume":"12","author":"VP Nair","year":"2016","unstructured":"Nair VP, Anang S, Subramani C, Madhvi A, Bakshi K, Srivastava A, Nayak B, Kumar CTR, Surjit M (2016) Endoplasmic reticulum stress induced synthesis of a novel viral factor mediates efficient replication of genotype-1 hepatitis E virus. PLoS Pathog 12:e1005521","journal-title":"PLoS Pathog"},{"issue":"1","key":"7_CR17","doi-asserted-by":"publisher","first-page":"e00135","DOI":"10.1128\/mSystems.00135-17","volume":"3","author":"C Subramani","year":"2018","unstructured":"Subramani C, Nair VP, Anang S, Mandal SD, Pareek M, Kaushik N, Srivastava A, Saha S, Nayak B, Ranjith-Kumar CT, Surjit M (2018) Host-virus protein interaction network reveals the involvement of multiple host processes in the life cycle of hepatitis E virus. mSystems 3(1):e00135\u2013e00117","journal-title":"mSystems"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12038-008-0064-1","volume":"33","author":"V Chandra","year":"2008","unstructured":"Chandra V, Taneja S, Kalia M, Jameel S (2008) Molecular biology and pathogenesis of hepatitis E virus. J Biosci 33:451\u2013464","journal-title":"J Biosci"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1006\/prep.1997.0817","volume":"12","author":"RA Robinson","year":"1998","unstructured":"Robinson RA, Burgess WH, Emerson SU, Leibowitz RS, Sosnovtseva SA, Tsarev S, Purcell RH (1998) Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 12:75\u201384","journal-title":"Protein Expr Purif"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1128\/JVI.73.5.4074-4082.1999","volume":"73","author":"M Zafrullah","year":"1999","unstructured":"Zafrullah M, Ozdener MH, Kumar R, Panda SK, Jameel S (1999) Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J Virol 73:4074\u20134082","journal-title":"J Virol"},{"issue":"8","key":"7_CR21","first-page":"e17","volume":"1","author":"D Cao","year":"2012","unstructured":"Cao D, Meng XJ (2012) Molecular biology and replication of hepatitis E virus. Emerg Microbes Infect 1(8):e17","journal-title":"Emerg Microbes Infect"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1099\/vir.0.034835-0","volume":"92","author":"TC Li","year":"2011","unstructured":"Li TC, Yoshimatsu K, Yasuda SP, Arikawa J, Koma T, Kataoka M, Ami Y, Suzaki Y, Mai LT, Hoa NT, Yamashiro T (2011) Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses. J Gen Virol 92:2830","journal-title":"J Gen Virol"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.vaccine.2003.08.004","volume":"22","author":"TC Li","year":"2004","unstructured":"Li TC, Suzaki Y, Ami Y, Dhole TN, Miyamura T, Takeda N (2004) Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 22:370\u2013377","journal-title":"Vaccine"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"33175","DOI":"10.1074\/jbc.M110.106336","volume":"285","author":"L Xing","year":"2010","unstructured":"Xing L, Li TC, Mayazaki N, Simon MN, Wall JS, Moore M, Wang CY, Takeda N, Wakita T, Miyamura T, Cheng RH (2010) Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 285:33175\u201333183","journal-title":"J Biol Chem"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.vetimm.2012.04.026","volume":"148","author":"E Crisci","year":"2012","unstructured":"Crisci E, B\u00e1rcena J, Montoya M (2012) Virus-like particles: the new frontier of vaccines for animal viral infections. Vet Immunol Immunopathol 148:211\u2013225","journal-title":"Vet Immunol Immunopathol"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1073\/pnas.1131929100","volume":"100","author":"K Murata","year":"2003","unstructured":"Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, Liang TJ (2003) Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci 100:6753\u20136758","journal-title":"Proc Natl Acad Sci"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","volume":"40","author":"EV Grgacic","year":"2006","unstructured":"Grgacic EV, Anderson DA (2006) Virus-like particles: passport to immune recognition. Methods 40:60\u201365","journal-title":"Methods"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","volume":"63","author":"GM Keating","year":"2003","unstructured":"Keating GM, Noble S (2003) Recombinant hepatitis B vaccine (Engerix-B (R))\u2014a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 63:1021\u20131051","journal-title":"Drugs"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cbpa.2016.03.001","volume":"32","author":"JT Bryan","year":"2016","unstructured":"Bryan JT, Buckland B, Hammond J, Jansen KU (2016) Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine. Curr Opin Chem Biol 32:34\u201347","journal-title":"Curr Opin Chem Biol"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1007\/s00253-014-5732-5","volume":"98","author":"M Ahmad","year":"2014","unstructured":"Ahmad M, Hirz M, Pichler H, Schwab H (2014) Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 98:5301\u20135317","journal-title":"Appl Microbiol Biotechnol"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12033-019-00164-8","volume":"61","author":"R Baghban","year":"2019","unstructured":"Baghban R, Farajnia S, Rajabibazl M, Ghasemi Y, Mafi A, Hoseinpoor R, Rahbarnia L, Aria M (2019) Yeast expression systems: overview and recent advances. Mol Biotechnol 61:365\u2013384","journal-title":"Mol Biotechnol"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-61779-770-5_2","volume":"866","author":"RA Darby","year":"2012","unstructured":"Darby RA, Cartwright SP, Dilworth MV, Bill RM (2012) Which yeast species shall I choose? Saccharomyces cerevisiae versus Pichia pastoris (review). Methods Mol Biol 866:11\u201323","journal-title":"Methods Mol Biol"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jbiotec.2015.01.027","volume":"202","author":"SC Spohner","year":"2015","unstructured":"Spohner SC, M\u00fcller H, Quitmann H, Czermak P (2015) Expression of enzymes for the usage in food and feed industry with Pichia pastoris. J Biotechnol 202:118\u2013134","journal-title":"J Biotechnol"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fmicb.2020.00141","volume":"11","author":"J Gupta","year":"2020","unstructured":"Gupta J, Kaul S, Srivastava A, Kaushik N, Ghosh S, Sharma C, Batra G, Banerjee M, Nayak B, Ranjith-Kumar CT, Surjit M (2020) Expression, purification and characterization of the hepatitis E virus like-particles in the Pichia pastoris. Front Microbiol 11:141","journal-title":"Front Microbiol"},{"key":"7_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006191","volume":"12","author":"V Ramasamy","year":"2018","unstructured":"Ramasamy V, Arora U, Shukla R, Poddar A, Shanmugam RK, White LJ, Mattocks MM, Raut R, Perween A, Tyagi P, de Silva AM (2018) A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice. PLoS Negl Trop Dis 12:e0006191","journal-title":"PLoS Negl Trop Dis"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/jfd.12037","volume":"36","author":"JY Seo","year":"2013","unstructured":"Seo JY, Chung HJ, Kim TJ (2013) Codon optimized expression of fish iridovirus capsid protein in yeast and its application as an oral vaccine candidate. J Fish Dis 36:763\u2013768","journal-title":"J Fish Dis"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.antiviral.2016.06.004","volume":"132","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Shen C, Zhang C, Zhang W, Wang L, Lan K, Liu Q, Huang ZY (2016) Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice. Antiviral Res 132:165\u2013169","journal-title":"Antiviral Res"},{"issue":"4","key":"7_CR38","doi-asserted-by":"publisher","first-page":"e17157","DOI":"10.5812\/jjm.8(4)2015.17157","volume":"8","author":"M Fazlalipour","year":"2015","unstructured":"Fazlalipour M, Keyvani H, Monavari SH, Mollaie HR (2015) Expression, purification and immunogenic description of a hepatitis C virus recombinant CoreE1E2 protein expressed by yeast Pichia pastoris. Jundishapur J Microbiol 8(4):e17157","journal-title":"Jundishapur J Microbiol"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.antiviral.2016.08.001","volume":"133","author":"M Pietrzak","year":"2016","unstructured":"Pietrzak M, Macio\u0142a A, Zdanowski K, Protas-Klukowska AM, Olszewska M, \u015amietanka K, Minta Z, Szewczyk B, Kopera E (2016) An avian influenza H5N1 virus vaccine candidate based on the extracellular domain produced in yeast system as subviral particles protects chickens from lethal challenge. Antiviral Res 133:242\u2013249","journal-title":"Antiviral Res"},{"key":"7_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/btpr.343","volume":"26","author":"JL Wasilenko","year":"2010","unstructured":"Wasilenko JL, Sarmento L, Spatz S, Pantin-Jackwood M (2010) Cell surface display of highly pathogenic avian influenza virus hemagglutinin on the surface of Pichia pastoris cells using \u03b1-agglutinin for production of oral vaccines. Biotechnol Prog 26:542\u2013547","journal-title":"Biotechnol Prog"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1128\/IAI.00170-08","volume":"76","author":"EJ Remarque","year":"2008","unstructured":"Remarque EJ, Faber BW, Kocken CH, Thomas AW (2008) A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect Immunity 76:2660\u20132670","journal-title":"Infect Immunity"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1908-7","volume":"16","author":"D Jacob","year":"2017","unstructured":"Jacob D, Ruffie C, Combredet C, Formaglio P, Amino R, M\u00e9nard R, Tangy F, Sala M (2017) Yeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen. Malaria J 16:1\u20134","journal-title":"Malaria J"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1862-1","volume":"9","author":"AM Gimenez","year":"2016","unstructured":"Gimenez AM, Fran\u00e7oso KS, Ersching J, Icimoto MY, Oliveira V, Rodriguez AE, Schnittger L, Florin-Christensen M, Rodrigues MM, Soares IS (2016) A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a 1, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-\u03b3 producing cells. Parasite Vectors 9:1\u20133","journal-title":"Parasite Vectors"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pep.2010.09.002","volume":"75","author":"AF Boulang\u00e9","year":"2011","unstructured":"Boulang\u00e9 AF, Khamadi SA, Pillay D, Coetzer TH, Authi\u00e9 E (2011) Production of congopain, the major cysteine protease of Trypanosoma (Nannomonas) congolense, in Pichia pastoris reveals unexpected dimerisation at physiological pH. Protein Expr Purif 75:95\u2013103","journal-title":"Protein Expr Purif"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pep.2010.09.016","volume":"75","author":"MP Dux","year":"2011","unstructured":"Dux MP, Huang J, Barent R, Inan M, Swanson ST, Sinha J, Ross JT, Smith LA, Smith TJ, Henderson I, Meagher MM (2011) Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC (Hc)] expressed in Pichia pastoris. Protein Expr Purif 75:177\u2013185","journal-title":"Protein Expr Purif"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pep.2009.11.001","volume":"70","author":"SM Ebrahimi","year":"2010","unstructured":"Ebrahimi SM, Tebianian M, Toghyani H, Memarnejadian A, Attaran HR (2010) Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris. Protein Expr Purif 70:7\u201312","journal-title":"Protein Expr Purif"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.vaccine.2007.12.005","volume":"26","author":"H Kohama","year":"2008","unstructured":"Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T (2008) Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guerin (BCG) in infected mice. Vaccine 26:924\u2013932","journal-title":"Vaccine"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00284-013-0505-4","volume":"68","author":"DD Hartwig","year":"2014","unstructured":"Hartwig DD, Bacelo KL, de Oliveira PD, Oliveira TL, Seixas FK, Amaral MG, Hartleben CP, McBride AJ, Dellagostin OA (2014) Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosis. Curr Microbiol 68:524\u2013530","journal-title":"Curr Microbiol"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.4161\/hv.25788","volume":"9","author":"W Cheng","year":"2013","unstructured":"Cheng W, Curti E, Rezende WC, Kwityn C, Zhan B, Gillespie P, Plieskatt J, Joshi SB, Volkin DB, Hotez PJ, Middaugh CR (2013) Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis. Hum Vaccin Immunother 9:2351\u20132361","journal-title":"Hum Vaccin Immunother"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.pep.2017.04.002","volume":"134","author":"L Damasceno","year":"2017","unstructured":"Damasceno L, Ritter G, Batt GA (2017) Process development for production and purification of the Schistosoma mansoni Sm14 antigen. Protein Expr Purif 134:72\u201381","journal-title":"Protein Expr Purif"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.4161\/21645515.2014.979606","volume":"10","author":"A Bolhassani","year":"2014","unstructured":"Bolhassani A, Muller M, Roohvand F, Motevalli F, Agi E, Shokri M, Rad MM, Hosseinzadeh S (2014) Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania. Hum Vaccin Immunother 10:3499\u20133508","journal-title":"Hum Vaccin Immunother"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/21655979.2016.1191707","volume":"7","author":"M Wang","year":"2016","unstructured":"Wang M, Jiang S, Wang Y (2016) Recent advances in the production of recombinant subunit vaccines in Pichia pastoris. Bioengineered 7:155\u2013165","journal-title":"Bioengineered"},{"issue":"9","key":"7_CR53","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1002\/jcp.29583","volume":"235","author":"M Karbalaei","year":"2020","unstructured":"Karbalaei M, Rezaee SA, Farsiani H (2020) Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins. J Cell Physiol 235(9):5867\u20135881","journal-title":"J Cell Physiol"},{"key":"7_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn369","volume":"36","author":"FS Hartner","year":"2008","unstructured":"Hartner FS, Ruth C, Langenegger D, Johnson SN, Hyka P, Lin-Cereghino GP, Lin-Cereghino J, Kovar K, Cregg JM, Glieder A (2008) Promoter library designed for fine-tuned gene expression in Pichia pastoris. Nucleic Acids Res 36:e76","journal-title":"Nucleic Acids Res"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12010-007-0003-x","volume":"142","author":"P Li","year":"2007","unstructured":"Li P, Anumanthan A, Gao XG, Ilangovan K, Suzara VV, D\u00fczg\u00fcne\u015f N, Renugopalakrishnan V (2007) Expression of recombinant proteins in Pichia pastoris. Appl Biochem Biotechnol 142:105\u2013124","journal-title":"Appl Biochem Biotechnol"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00253-011-3654-z","volume":"93","author":"LM Damasceno","year":"2012","unstructured":"Damasceno LM, Huang CJ, Batt CA (2012) Protein secretion in Pichia pastoris and advances in protein production. Appl Microbiol Biotechnol 93:31\u201339","journal-title":"Appl Microbiol Biotechnol"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.vaccine.2008.12.061","volume":"27","author":"J Zhang","year":"2009","unstructured":"Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, Luo D, Pan BB, Nong Y, Ge SX, Xiong JH (2009) Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 27:1869\u20131874","journal-title":"Vaccine"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4161\/hv.20042","volume":"8","author":"T Wu","year":"2012","unstructured":"Wu T, Li SW, Zhang J, Ng MH, Xia NS, Zhao Q (2012) Hepatitis E vaccine development: a 14 year odyssey. Hum Vaccin Immunother 8:823\u2013827","journal-title":"Hum Vaccin Immunother"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","volume":"376","author":"FC Zhu","year":"2010","unstructured":"Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376:895\u2013902","journal-title":"Lancet"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1406011","volume":"372","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, Guo M (2015) Long-term efficacy of a hepatitis E vaccine. N Engl J Med 372:914\u2013922","journal-title":"N Engl J Med"},{"key":"7_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1046-5928(02)00574-0","volume":"27","author":"D Sehgal","year":"2003","unstructured":"Sehgal D, Malik PS, Jameel S (2003) Purification and diagnostic utility of a recombinant hepatitis E virus capsid protein expressed in insect larvae. Protein Expr Purif 27:27\u201334","journal-title":"Protein Expr Purif"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1016\/S0264-410X(02)00314-6","volume":"20","author":"M Zhang","year":"2002","unstructured":"Zhang M, Emerson SU, Nguyen H, Engle R, Govindarajan S, Blackwelder WC, Gerin J, Purcell RH (2002) Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 20:3285\u20133291","journal-title":"Vaccine"},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1128\/JVI.78.9.4838-4846.2004","volume":"78","author":"SU Emerson","year":"2004","unstructured":"Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH (2004) In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol 78:4838\u20134846","journal-title":"J Virol"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1892-9_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T10:05:07Z","timestamp":1699956307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1892-9_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"ISBN":["9781071618912","9781071618929"],"references-count":63,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1892-9_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"17 December 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}